undamentalytics Newsletter
Sign in

Accendra Health Inc revenue

Accendra Health Inc's revenue was $2.76bn in fiscal 2025, up 3.1% on the year before. Since fiscal 2009 ($8.04bn) it has grown at a compound -6.5% a year. Over the last twelve months it was $2.65bn.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue8,0388,1248,6288,8689,0729,4409,7739,7239,3189,4189,2118,4809,7859,9552,5532,6802,7622,647
Growth on the year before—+1.1%+6.2%+2.8%+2.3%+4.1%+3.5%−0.5%−4.2%+1.1%−2.2%−7.9%+15.4%+1.7%−74.4%+5.0%+3.1%—
Gross profit8148088589251,1171,1701,2151,1871,1721,0711,1281,2811,5131,8262,1252,2191,2891,187
Gross margin10.1%9.9%9.9%10.4%12.3%12.4%12.4%12.2%12.6%11.4%12.3%15.1%15.5%18.3%83.3%82.8%46.7%44.8%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue Share YoY
Diabetes Product $783M 28.4% ▲ 0.8%
Sleep Therapy Product $740M 26.8% ▲ 5.3%
Home Respiratory Therapy Product $433M 15.7% ▼ 0.7%
Other $288M 10.4% ▲ 7.4%
Ostomy $213M 7.7% ▲ 8.6%
Wound Care $189M 6.8% ▼ 2.0%
Urology $116M 4.2% ▲ 8.3%

From Accendra Health Inc's 10-K filed February 20, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Distributors: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Accendra Health Inc $2.65bn -3.3% -36.1%
111, Inc. $1.75bn -12.7% —
Henry Schein $13.60bn 6.5% 2.6%
Cosmos Health Inc. $73.7m 33.8% 14.8%
Cencora $332.77bn 5.1% 9.4%
McKesson $410.98bn 8.8% 13.1%

Compare with peers

Head to head: ACH vs YIACH vs HSICACH vs COSM

More: Health Care Distributors stocks compared, Health Care sector, rankings of US companies

Figures from Accendra Health Inc's SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Accendra Health Inc.